Obese children, teens on metformin show reduced BMI

11/27/2012 | Healio

Obese children and adolescents with hyperinsulinemia and/or impaired fasting glucose or impaired glucose tolerance who took metformin daily for six months attained significant reductions in BMI compared with those in the placebo group, a study found. Improvements in fasting glucose, alanine aminotransferase and adiponectin-to-leptin ratio were also seen in metformin-treated patients, researchers noted. The findings appear in the Journal of Clinical Endocrinology & Metabolism.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC